Trial intelligence / Profile preview

Alprostadil as additional anticoagulant in veno-venous ECMO

2015-005014-30Phase 3Completed

Sponsor
Medical University of Vienna
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Vasostenoon in acute respiratory decompensation, pulmonary insufficiency (PR), sponsored by Medical University of Vienna. Started Apr 2016; status: completed.

02

Drugs

Vasostenoon
03

Conditions

acute respiratory decompensationpulmonary insufficiency (PR)

Beyond the preview

Go deeper on 2015-005014-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005014-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call